Daiichi Sankyo and AstraZeneca recently entered into a second clinical trial collaboration and supply agreement with Merck to evaluate an antibody-drug conjugate with Keytruda in patients with...
VisualDx and Janssen Biotech recently partnered to pilot a new application programming interface (API) and equitable artificial intelligence (AI) to enhance diagnostic accuracy.
The...
Cerner recently launched a new operating unit, Cerner Enviza, that offers data-driven solutions and research services to clarify multi-dimensional data through real-world evidence and...
FDA recently approved a new low-dose tablet dosage form of Gilead’s HIV-1 drug, Biktarvy, in pediatric patients.
The agency approved the new dosage for children weighing at least 30 pounds who...
Patient access to care and medication adherence have been ongoing challenges in the healthcare industry, especially during the COVID-19 pandemic. But pharmacists can play a valuable role in connecting...
FDA recently awarded 11 new clinical trial research grants, totaling $25 million over the next four years to support the development of medical products for patients with rare diseases.
The...
Merck recently entered into an $11.5 billion pharma acquisition deal with biotechnology company Acceleron Pharma to strengthen its cardiovascular pipeline.
Acceleron focuses on transforming the...
Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that an early-stage compound with a novel mechanism of action could potentially treat all dengue virus...
Johnson & Johnson recently initiated a Phase 3 clinical trial to study its RSV vaccine's efficacy, safety, and immunogenicity against lower respiratory tract disease (LRTD) in adults.
The...
FDA recently approved Amgen’s Repatha to treat pediatric patients ten and older with autosomal dominant disease, heterozygous familial hypercholesterolemia (HeFH), to reduce low-density...
AstraZeneca recently submitted a request to FDA for an emergency use authorization for its long-acting COVID-19 antibody combination, AZD7442.
AstraZeneca optimized AZD7442 using its YTE half-life...
Johnson & Johnson recently announced that Xarelto elicited fewer blood clots and clinical events strongly associated with blood clots in pediatric patients compared to treatment with aspirin.
The...
Eli Lilly and Company recently announced it will lower the list price of Insulin Lispro Injection in the US by another 40 percent.
Effective January 1, 2022, the new list price will be $82.41 for...
Nearly 44 percent of adults ranked staying up to date on vaccines as important before the COVID-19 pandemic, rising to 65 percent after the pandemic, according to a new survey by Kantar on behalf of...
SAS and the University of North Carolina at Chapel Hill (UNC-Chapel Hill) recently partnered to transform the antiviral drug development process and prevent infectious disease threats from turning into...
AbbVie and Regenxbio recently partnered to develop and commercialize RGX-314, a potential one-time gene therapy to treat various chronic retinal diseases.
Researchers are currently evaluating...
PhRMA member companies encourage Congress to abandon old partisan ideas on drug pricing and pursue policies that address patients out of pocket costs, according to a new official letter.
The...
National Resilience recently entered into a multi-year agreement with Moderna to manufacture drug substance mRNA for its COVID-19 vaccine.
Resilience is a manufacturing and technology company...
Moderna and the Institute for Life Changing Medicines (ILCM) recently collaborated to develop a new mRNA therapeutic (mRNA-3351) for ultra-rare disease, Crigler-Najjar Syndrome Type 1...
